Manufacturers Life Insurance Company, The Spero Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $8,598 - $86,452	-11,620 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$7.87 - $15.15 $91,449 - $176,043	11,620 New	11,620 $101,000
Q1 2022 May 20, 2022	SELL	$7.87 - $15.15 $19,171 - $36,905	-2,436 Reduced 17.33%	11,620 $101,000
Q4 2021 Feb 16, 2022	SELL	$13.09 - $18.77 $2,879 - $4,129	-220 Reduced 1.54%	14,056 $225,000
Q3 2021 Nov 12, 2021	SELL	$13.03 - $19.51 $21,694 - $32,484	-1,665 Reduced 10.44%	14,276 $263,000
Q2 2021 Aug 12, 2021	BUY	$12.22 - $15.79 $30,354 - $39,222	2,484 Added 18.46%	15,941 $223,000
Q1 2021 May 03, 2021	BUY	$13.23 - $21.48 $1,203 - $1,954	91 Added 0.68%	13,457 $198,000
Q4 2020 Feb 12, 2021	BUY	$11.65 - $22.07 $155,713 - $294,987	13,366 New	13,366 $259,000
Q3 2018 Nov 14, 2018	SELL	$9.69 - $17.79 $6,434 - $11,812	-664 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$10.41 - $17.85 $645 - $1,106	-62 Reduced 8.54%	664 $10,000
Q1 2018 May 15, 2018	SELL	$9.96 - $14.61 $4,003 - $5,873	-402 Reduced 35.64%	726 $10,000
Q4 2017 Feb 08, 2018	BUY	$10.43 - $14.75 $11,765 - $16,638	1,128	1,128 $13,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.